Since NF-kB is a key transcription factor that mediates inflammatory response including cytokine production [40], we hypothesized that ING4-deficient tumors may harbor an immune microenvironment resulting from aberrant NF-kB activity, which in turn contributes to aggressive tumor progression. This evidence concerns the gene NFKB1 and neoplasm.